These findings indicate that targeting the IL‐7 receptor signalling as well as genetic loss of Xbp1 activates the Ras–Erk signalling pathway in pre‐B NRASG12D ALL cells. This evidence concerns the gene XBP1 and acute lymphoblastic leukemia.